1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 43, 26/Oct/2017
  4. Article
Systematic Review Open Access
Like 0
Download

Abstract

Background: Sporadic Creutzfeldt–Jakob disease (sCJD) is potentially transmissible to humans. Objective: This study aimed to summarise and rate the quality of the evidence of the association between surgery and sCJD. Design and methods: Firstly, we conducted systematic reviews and meta-analyses of case–control studies with major surgical procedures as exposures under study. To assess quality of evidence, we used the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. Secondly, we conducted a systematic review of sCJD case reports after sharing neurosurgical instruments. Results: Thirteen case–control studies met the inclusion criteria for the systematic review of case–control studies. sCJD was positively associated with heart surgery, heart and vascular surgery and eye surgery, negatively associated with tonsillectomy and appendectomy, and not associated with neurosurgery or unspecified major surgery. The overall quality of evidence was rated as very low. A single case–control study with a low risk of bias found a strong association between surgery conducted more than 20 years before disease onset and sCJD. Seven cases were described as potentially transmitted by reused neurosurgical instruments. Conclusion: The association between surgery and sCJD remains uncertain. Measures currently recommended for preventing sCJD transmission should be strongly maintained. Future studies should focus on the potential association between sCJD and surgery undergone a long time previously.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.43.16-00806
2017-10-26
2024-12-22
/content/10.2807/1560-7917.ES.2017.22.43.16-00806
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/43/eurosurv-22-43-4.html?itemId=/content/10.2807/1560-7917.ES.2017.22.43.16-00806&mimeType=html&fmt=ahah

References

  1. Prusiner SB. The prion diseases. Brain Pathol. 1998;8(3):499-513.  https://doi.org/10.1111/j.1750-3639.1998.tb00171.x  PMID: 9669700 
  2. Weissmann C, Enari M, Klöhn PC, Rossi D, Flechsig E. Transmission of prions. Proc Natl Acad Sci USA. 2002;99(Suppl 4):16378-83.  https://doi.org/10.1073/pnas.172403799  PMID: 12181490 
  3. European Centre for Disease Control and Prevention (ECDC). Creutzfeldt-Jakob disease. EU case definition. Stockholm: ECDC. [Accessed: 5 Oct 2016]. Available from: https://ecdc.europa.eu/en/infectious-diseases-public-health/variant-creutzfeldt-jakob-disease/eu-case-definition
  4. Rábano A, de Pedro-Cuesta J, Mølbak K, Siden A, Calero M, Laursen HEUROSURGYCJD Research Group. Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels. BMC Public Health. 2005;5(1):9.  https://doi.org/10.1186/1471-2458-5-9  PMID: 15667663 
  5. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;35(5):513-29.  https://doi.org/10.1002/ana.410350504  PMID: 8179297 
  6. World Health Organization (WHO). WHO tables on tissue infectivity distribution in transmissible spongiform encephalopathies. Geneva: WHO; 2010. Contract No.: WHO/EMP/QSM/2010.1. Available from: http://www.who.int/bloodproducts/tablestissueinfectivity.pdf
  7. de Pedro Cuesta J, Ruiz Tovar M, Ward H, Calero M, Smith A, Verduras CA, et al. Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease. Neuroepidemiology. 2012;39(1):1-18.  https://doi.org/10.1159/000339318  PMID: 22777385 
  8. European Centre for Disease Control and Prevention (ECDC). Review of guidelines for prevention of Creutzfeldt-Jakob disease transmission in medical settings in EU Member States and Norway. Stockholm: ECDC; 2011. Available from: http://ecdc.europa.eu/en/publications/Publications/1106_TER_Review_of_guidelines_for_prevention_of%20CJD.pdf
  9. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. [Accessed: 5 Oct 2016.] Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.  https://doi.org/10.1016/0197-2456(86)90046-2  PMID: 3802833 
  11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.  https://doi.org/10.1136/bmj.327.7414.557  PMID: 12958120 
  12. Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008;37(5):1148-57.  https://doi.org/10.1093/ije/dyn065  PMID: 18424475 
  13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34.  https://doi.org/10.1136/bmj.315.7109.629  PMID: 9310563 
  14. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-63.  https://doi.org/10.1111/j.0006-341X.2000.00455.x  PMID: 10877304 
  15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6.  https://doi.org/10.1136/bmj.39489.470347.AD  PMID: 18436948 
  16. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-94.  https://doi.org/10.1016/j.jclinepi.2010.04.026  PMID: 21195583 
  17. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6.  https://doi.org/10.1016/j.jclinepi.2010.07.015  PMID: 21208779 
  18. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 1999;353(9154):693-7.  https://doi.org/10.1016/S0140-6736(98)08138-0  PMID: 10073510 
  19. Mahíllo-Fernández I, de Pedro-Cuesta J, Bleda MJ, Cruz M, Mølbak K, Laursen H, et al. EUROSURGYCJD Research Group. Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology. 2008;31(4):229-40.  https://doi.org/10.1159/000163097  PMID: 18843192 
  20. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Gillies M, Murray K, et al. Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2008;63(3):347-54.  https://doi.org/10.1002/ana.21294  PMID: 18074392 
  21. de Pedro-Cuesta J, Mahillo-Fernández I, Rábano A, Calero M, Cruz M, Siden A, et al. EUROSURGYCJD Research Group. Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry. 2011;82(2):204-12.  https://doi.org/10.1136/jnnp.2009.188425  PMID: 20547628 
  22. Zerr I, Brandel JP, Masullo C, Wientjens D, de Silva R, Zeidler M, et al. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol. 2000;53(7):747-54.  https://doi.org/10.1016/S0895-4356(99)00207-3  PMID: 10941953 
  23. Ward HJ, Everington D, Croes EA, Alperovitch A, Delasnerie-Lauprêtre N, Zerr I, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology. 2002;59(4):543-8.  https://doi.org/10.1212/WNL.59.4.543  PMID: 12196646 
  24. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, et al. Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008. Emerg Infect Dis. 2009;15(2):265-71.  https://doi.org/10.3201/eid1502.080749  PMID: 19193271 
  25. Ruegger J, Stoeck K, Amsler L, Blaettler T, Zwahlen M, Aguzzi A, et al. A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004. BMC Public Health. 2009;9(1):18.  https://doi.org/10.1186/1471-2458-9-18  PMID: 19144172 
  26. de Pedro-Cuesta J, Mahíllo-Fernández I, Calero M, Rábano A, Cruz M, Siden Å, et al. EUROSURGYCJD Research Group. Towards an age-dependent transmission model of acquired and sporadic Creutzfeldt-Jakob disease. PLoS One. 2014;9(10):e109412.  https://doi.org/10.1371/journal.pone.0109412  PMID: 25279832 
  27. Nakamura Y, Oki I, Tanihara S, Ojima T, Yanagawa H, Kitamoto T, et al. A case-control study of Creutzfeldt-Jakob disease in Japan: transplantation of cadaveric dura mater was a risk factor. J Epidemiol. 2000;10(6):399-402.  https://doi.org/10.2188/jea.10.399  PMID: 11210109 
  28. Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry. 1988;51(9):1113-9.  https://doi.org/10.1136/jnnp.51.9.1113  PMID: 3066847 
  29. Laske C, Gefeller O, Pfahlberg A, Zerr I, Schröter A, Poser S. The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study. Eur J Epidemiol. 1999;15(7):631-5.  https://doi.org/10.1023/A:1007683208121  PMID: 10543352 
  30. Puopolo M, Ladogana A, Vetrugno V, Pocchiari M. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion. 2011;51(7):1556-66.  https://doi.org/10.1111/j.1537-2995.2010.03004.x  PMID: 21214582 
  31. Nevin S, McMENEMEY WH, Behrman S, Jones DP. Subacute spongiform encephalopathy--a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain. 1960;83(4):519-64.  https://doi.org/10.1093/brain/83.4.519  PMID: 13728615 
  32. el Hachimi KH, Chaunu MP, Cervenakova L, Brown P, Foncin JF. Putative neurosurgical transmission of Creutzfeldt-Jakob disease with analysis of donor and recipient: agent strains. C R Acad Sci III. 1997;320(4):319-28.  https://doi.org/10.1016/S0764-4469(97)82774-6  PMID: 9183437 
  33. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977;1(8009):478-9.  https://doi.org/10.1016/S0140-6736(77)91958-4  PMID: 65575 
  34. Stricof RL, Lillquist PP, Thomas N, Belay ED, Schonberger LB, Morse DL. An investigation of potential neurosurgical transmission of Creutzfeldt-Jakob disease: challenges and lessons learned. Infect Control Hosp Epidemiol. 2006;27(3):302-4.  https://doi.org/10.1086/503017  PMID: 16532420 
  35. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ. 1998;316(7125):140-4.  https://doi.org/10.1136/bmj.316.7125.140  PMID: 9462324 
  36. Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry. 1994;57(6):757-8.  https://doi.org/10.1136/jnnp.57.6.757  PMID: 8006664 
  37. Cruz M, Mahíllo-Fernández I, Rábano A, Siden A, Calero M, Laursen H, et al. Late-in-life surgery associated with Creutzfeldt-Jakob disease: a methodological outline for evidence-based guidance. Emerg Themes Epidemiol. 2013;10(1):5.  https://doi.org/10.1186/1742-7622-10-5  PMID: 23701872 
  38. Koperek O, Kovács GG, Ritchie D, Ironside JW, Budka H, Wick G. Disease-associated prion protein in vessel walls. Am J Pathol. 2002;161(6):1979-84.  https://doi.org/10.1016/S0002-9440(10)64474-4  PMID: 12466112 
  39. de Pedro-Cuesta J, Martínez-Martín P, Rábano A, Alcalde-Cabero E, José García López F, Almazán-Isla J, et al. Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders. J Alzheimers Dis. 2016;51(4):1003-22.  https://doi.org/10.3233/JAD-150884  PMID: 26923014 
  40. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proc Biol Sci. 2003;270(1516):689-698.
  41. Boëlle PY, Cesbron JY, Valleron AJ. Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect Dis. 2004;4(1):26.  https://doi.org/10.1186/1471-2334-4-26  PMID: 15304199 
  42. de Pedro-Cuesta J, Gudmundsson G, Abraira V, Gudmundsson G, Löve A, Tulinius H, et al. Whooping cough and Parkinson’s disease. Int J Epidemiol. 1996;25(6):1301-11.  https://doi.org/10.1093/ije/25.6.1301  PMID: 9027539 
  43. Moceri VM, Kukull WA, Emanuel I, van Belle G, Larson EB. Early-life risk factors and the development of Alzheimer’s disease. Neurology. 2000;54(2):415-20.  https://doi.org/10.1212/WNL.54.2.415  PMID: 10668705 
  44. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ Res. 2001;86(2):122-7.  https://doi.org/10.1006/enrs.2001.4264  PMID: 11437458 
  45. de Pedro-Cuesta J, Martínez-Martín P, Rábano A, Ruiz-Tovar M, Alcalde-Cabero E, Calero M. Etiologic framework for the study of neurodegenerative disorders as well as vascular and metabolic comorbidities on the grounds of shared epidemiologic and biologic features. Front Aging Neurosci. 2016;8:138.  https://doi.org/10.3389/fnagi.2016.00138  PMID: 27378910 
  46. Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA. 2015;112(38):E5308-17.  https://doi.org/10.1073/pnas.1514475112  PMID: 26324905 
Risk of transmission of sporadic Creutzfeldt-Jakob disease by surgical procedures: systematic reviews and quality of evidence
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Fernando+J+Garc%C3%ADa+L%C3%B3pez&option1=author&noRedirect=true" class="nonDisambigAuthorLink">López Fernando J García</a>, <a href="/search?value1=Mar%C3%ADa+Ruiz-Tovar&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ruiz-Tovar María</a>, <a href="/search?value1=Javier+Almaz%C3%A1n-Isla&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Almazán-Isla Javier</a>, <a href="/search?value1=Enrique+Alcalde-Cabero&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Alcalde-Cabero Enrique</a>, <a href="/search?value1=Miguel+Calero&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Calero Miguel</a>, <a href="/search?value1=Jes%C3%BAs+de+Pedro-Cuesta&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Pedro-Cuesta Jesús</a></span>. Risk of transmission of sporadic Creutzfeldt-Jakob disease by surgical procedures: systematic reviews and quality of evidence. <a href="/content/ecdc">Euro Surveill.</a> 2017;22(43):pii=16-00806. <a href="https://doi.org/10.2807/1560-7917.ES.2017.22.43.16-00806" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.43.16-00806</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 09 Dec 2016;&nbsp;&nbsp; <span class="generated">Accepted</span>: 19 Apr 2017 </span> </p>
/content/10.2807/1560-7917.ES.2017.22.43.16-00806
/content/10.2807/1560-7917.ES.2017.22.43.16-00806
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error